CXCR4 and neoplasm: Depending on the tumor type, expression of CXCR4 has been reported in 20%-80% of cases, where it has been implicated in multiple processes, including tumor growth, invasion of adjacent tissue, metastasis, and resistance to therapy [2, 3, 8-12].